2006
DOI: 10.1002/jps.20466
|View full text |Cite
|
Sign up to set email alerts
|

A Process Analytical Technology approach to near-infrared process control of pharmaceutical powder blending: Part II: Qualitative near-infrared models for prediction of blend homogeneity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
36
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 90 publications
(36 citation statements)
references
References 18 publications
(22 reference statements)
0
36
0
Order By: Relevance
“…The powder discharge is also called "powder voiding," a term that is referred to in part I, and it is equivalent to emptying of a container and the ensuing discharge of the powder. It is shown that NIR may be used to obtain information on the flow properties of powders and increase process knowledge in addition to the already developed pharmaceutical applications that include blend uniformity analysis, drug concentration in tablets, and evaluation of moisture in drying granulations [23][24][25][26][27][28][29]. The NIR method complements previous efforts based on powder avalanching and NIR spectroscopy [30][31][32].…”
Section: Introductionmentioning
confidence: 89%
“…The powder discharge is also called "powder voiding," a term that is referred to in part I, and it is equivalent to emptying of a container and the ensuing discharge of the powder. It is shown that NIR may be used to obtain information on the flow properties of powders and increase process knowledge in addition to the already developed pharmaceutical applications that include blend uniformity analysis, drug concentration in tablets, and evaluation of moisture in drying granulations [23][24][25][26][27][28][29]. The NIR method complements previous efforts based on powder avalanching and NIR spectroscopy [30][31][32].…”
Section: Introductionmentioning
confidence: 89%
“…Generally, a minimum of 10 blend samples of 1-3 times the dosage unit weight must be taken at different locations according to the blender used, and the mean of the blend samples must be between 90.0 and 110.0% of the theoretical drug content with a RSD ≤ 5% to have an acceptable degree of homogeneity [108]. In the last decade, methods based on the implementation of process analytical technology that determine blend uniformity in process (i.e., without removal of samples from the mixer) have been developed and are primarily based on near infrared spectroscopy [109][110][111][112]. These eliminate many of the problems associated with blend sampling error and bias.…”
Section: Drug Distribution Uniformitymentioning
confidence: 99%
“…At time t ¼ 1, the initial probability of the states is p ¼ {p i }, where: In summary, a HMM can be described by the following notation l¼ ðA;B;pÞ (10) The HMM model describes the both the static and dynamic features of the process in terms of probability.…”
Section: Hidden Markov Models and Decision Making A Brief Review Of Hmentioning
confidence: 99%
“…(10). First, assuming there are N p blending conditions (e.g., not blended, partially blended, completely blended, etc.)…”
Section: Trainingmentioning
confidence: 99%